David Southwell
2022
In 2022, David Southwell earned a total compensation of $2.1M as Former President, Chief Executive Officer and Director at TScan Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $342,232 |
|---|---|
| Option Awards | $1,169,353 |
| Salary | $622,239 |
| Other | $8,920 |
| Total | $2,142,743 |
Southwell received $1.2M in option awards, accounting for 55% of the total pay in 2022.
Southwell also received $342.2K in non-equity incentive plan, $622.2K in salary and $8.9K in other compensation.
Rankings
In 2022, David Southwell's compensation ranked 1,662nd out of 5,756 executives tracked by ExecPay. In other words, Southwell earned more than 71.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,662 out of 5,756 | 71st |
Division Manufacturing | 864 out of 3,133 | 72nd |
Major group Chemicals And Allied Products | 343 out of 1,419 | 76th |
Industry group Drugs | 317 out of 1,320 | 76th |
Industry Biological Products, Except Diagnostic Substances | 78 out of 291 | 73rd |
Source: SEC filing on April 25, 2023.
Southwell's colleagues
We found two more compensation records of executives who worked with David Southwell at TScan Therapeutics in 2022.